Literature DB >> 11349740

Can the frequency and risks of fatal adverse drug events be determined?

W N Kelly1.   

Abstract

Death is the ultimate adverse drug event. Despite its importance, the frequency of fatal adverse drug events is unknown. Estimates in the United States are as high as 140,000/year, although this number is heavily disputed. Potential reasons and risks for fatal adverse drug events, as well as epidemiologic designs for studying this important public health issue, are discussed and issues are raised to promote further thought.

Mesh:

Year:  2001        PMID: 11349740     DOI: 10.1592/phco.21.6.521.34540

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  5 in total

1.  Analysis of risk factors for adverse drug events in critically ill patients*.

Authors:  Sandra L Kane-Gill; Levent Kirisci; Margaret M Verrico; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

2.  Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study.

Authors:  Lukas Schwake; Ines Wollenschläger; Wolfgang Stremmel; Jens Encke
Journal:  Intensive Care Med       Date:  2008-08-12       Impact factor: 17.440

3.  Systematic review of predictive risk models for adverse drug events in hospitalized patients.

Authors:  Nazanin Falconer; Michael Barras; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2018-02-22       Impact factor: 4.335

4.  [Practical limitations of medical clarification and informed consent in the context of drug therapy].

Authors:  Thomas Meyer; Melanie Steuer
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-09-01       Impact factor: 1.552

5.  Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a propensity score-matched analysis.

Authors:  Xiao-Bo Zhai; Zhi-Chun Gu; Xiao-Yan Liu
Journal:  Ther Clin Risk Manag       Date:  2016-02-18       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.